{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:27:36Z","timestamp":1793741256878,"version":"4.6.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ekir.2026.107038","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T23:41:30Z","timestamp":1787269290000},"page":"107038","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Systematic Review of Persistent Microscopic Hematuria and Kidney Outcomes in IgAN"],"prefix":"10.1016","volume":"11","author":[{"given":"Gian Marco","family":"Berti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Vetrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Tringali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Tondolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Cantarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gisella","family":"Vischini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Gessaroli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Comai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"La Manna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Maritati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2026.107038_bib1","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1056\/NEJMra1206793","article-title":"IgA nephropathy","volume":"368","author":"Wyatt","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ekir.2026.107038_bib2","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1053\/j.ajkd.2015.08.001","article-title":"AJKD Atlas of Renal Pathology: IgA nephropathy","volume":"66","author":"Fogo","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2026.107038_bib3","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1001\/jama.2025.25020","article-title":"IgA nephropathy in adults: a review","volume":"335","author":"Stoneman","year":"2026","journal-title":"JAMA"},{"key":"10.1016\/j.ekir.2026.107038_bib4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.5527\/wjn.v4.i2.185","article-title":"Pathogenesis of glomerular haematuria","volume":"4","author":"Yuste","year":"2015","journal-title":"World J Nephrol"},{"key":"10.1016\/j.ekir.2026.107038_bib5","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1093\/ndt\/gfz267","article-title":"The association of microhematuria with mesangial hypercellularity, endocapillary hypercellularity, crescent score and renal outcomes in immunoglobulin A nephropathy","volume":"36","author":"Bobart","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2026.107038_bib6","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1681\/ASN.2017060639","article-title":"Persistent microscopic hematuria as a risk factor for progression of IgA nephropathy: new floodlight on a nearly forgotten biomarker","volume":"28","author":"Coppo","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2026.107038_bib7","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2025.04.004","article-title":"KDIGO 2025 clinical practice guideline for the management of immunoglobulin A nephropathy (IgAN) and immunoglobulin A vasculitis (IgAV)","volume":"108","author":"Rovin","year":"2025","journal-title":"Kidney Int"},{"issue":"Suppl 2","key":"10.1016\/j.ekir.2026.107038_bib8","doi-asserted-by":"crossref","first-page":"ii19","DOI":"10.1093\/ckj\/sfad232","article-title":"Microscopic hematuria as a risk factor for IgAN progression: considering this biomarker in selecting and monitoring patients","volume":"16","author":"Zand","year":"2023","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.ekir.2026.107038_bib9","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1053\/j.ajkd.2019.11.008","article-title":"Persistent hematuria and kidney disease progression in IgA nephropathy: a cohort study","volume":"76","author":"Yu","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2026.107038_bib10","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1681\/ASN.2017010108","article-title":"Remission of hematuria improves renal survival in IgA nephropathy","volume":"28","author":"Sevillano","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2026.107038_bib11","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1093\/ndt\/gfag071","article-title":"Hematuria as a biomarker guiding treatment decisions in IgA nephropathy? no","volume":"41","author":"Cheung","year":"2026","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2026.107038_bib12","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1093\/ndt\/gfag072","article-title":"Hematuria as a biomarker guiding treatment decisions in IgA nephropathy? Yes","volume":"41","author":"Guti\u00e9rrez","year":"2026","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2026.107038_bib13","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/nep.14250","article-title":"Kidney outcomes associated with haematuria and proteinuria trajectories among patients with IgA nephropathy in real-world clinical practice: the Japan Chronic Kidney Disease Database","volume":"29","author":"Yano","year":"2024","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.ekir.2026.107038_bib14","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1007\/s11255-020-02457-3","article-title":"Renal survival and risk factors in IgA nephropathy with crescents","volume":"52","author":"Ma","year":"2020","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.ekir.2026.107038_bib15","doi-asserted-by":"crossref","first-page":"6785","DOI":"10.3390\/jcm11226785","article-title":"Time-averaged hematuria as a prognostic indicator of renal outcome in patients with IgA nephropathy","volume":"11","author":"Weng","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.ekir.2026.107038_bib16","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1159\/000529650","article-title":"Clinical significance of persistent hematuria degrees in primary IgA nephropathy: a propensity score-matched analysis of a 10-year follow-up cohort","volume":"54","author":"Huang","year":"2023","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.ekir.2026.107038_bib17","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1093\/ndt\/gfr527","article-title":"Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population","volume":"27","author":"Le","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2026.107038_bib18","article-title":"Time-updated hematuria and kidney disease progression in IgAN","volume":"11","author":"Tang","year":"2026","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.ekir.2026.107038_bib19","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.emc.2019.07.011","article-title":"The approach to the patient with hematuria","volume":"37","author":"Willis","year":"2019","journal-title":"Emerg Med Clin North Am"},{"key":"10.1016\/j.ekir.2026.107038_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091756","article-title":"Prognosis in IgA nephropathy: 30-year analysis of 1,012 patients at a single center in Japan","volume":"9","author":"Moriyama","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ekir.2026.107038_bib21","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1681\/ASN.0000000000000242","article-title":"Treatment of IgA nephropathy: a rapidly evolving field","volume":"35","author":"El Karoui","year":"2024","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2026.107038_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.semnephrol.2025.151573","article-title":"The rapidly changing treatment landscape of IgA nephropathy","volume":"44","author":"Cheung","year":"2024","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.ekir.2026.107038_bib23","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.kint.2025.01.014","article-title":"Treatment of patients with IgA nephropathy: a call for a new paradigm","volume":"107","author":"Floege","year":"2025","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2026.107038_bib24","author":"Cattran"},{"key":"10.1016\/j.ekir.2026.107038_bib25","doi-asserted-by":"crossref","first-page":"560","DOI":"10.2310\/JIM.0b013e3181d20aa1","article-title":"Clinicopathological characteristics and prognostic factors of asymptomatic IgA nephropathy","volume":"58","author":"Shen","year":"2010","journal-title":"J Investig Med"},{"key":"10.1016\/j.ekir.2026.107038_bib26","doi-asserted-by":"crossref","first-page":"F888","DOI":"10.1152\/ajprenal.00133.2023","article-title":"Kidney functional reserve and damage biomarkers in subclinical chronic kidney disease and acute kidney injury","volume":"325","author":"Taylor","year":"2023","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.ekir.2026.107038_bib27","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.kint.2017.02.003","article-title":"Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group","volume":"91","author":"Trimarchi","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2026.107038_bib28","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/ki.2009.243","article-title":"The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification","volume":"76","author":"Cattran","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2026.107038_bib29","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1681\/ASN.2007050526","article-title":"Toronto Glomerulonephritis Registry. Remission of proteinuria improves prognosis in IgA nephropathy","volume":"18","author":"Reich","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2026.107038_bib30","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfag003","article-title":"Microscopic hematuria in IgA nephropathy: a biomarker of disease activity","volume":"19","author":"Floege","year":"2026","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.ekir.2026.107038_bib31","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1093\/ndt\/gfae289","article-title":"Tailored management strategies for IgA nephropathy based on clinical presentations","volume":"40","author":"Praga","year":"2025","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2026.107038_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128575","article-title":"Haematuria increases progression of advanced proteinuric kidney disease","volume":"10","author":"Yuste","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ekir.2026.107038_bib33","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1291\/hypres.29.15","article-title":"Impact of hypertension and hypertension-related vascular lesions in IgA nephropathy","volume":"29","author":"Ikee","year":"2006","journal-title":"Hypertens Res"},{"key":"10.1016\/j.ekir.2026.107038_bib34","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s40620-020-00930-x","article-title":"Systolic blood pressure and chronic kidney disease progression in patients with primary glomerular disease","volume":"34","author":"Kim","year":"2021","journal-title":"J Nephrol"},{"key":"10.1016\/j.ekir.2026.107038_bib35","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/s41581-019-0145-4","article-title":"Obesity, kidney dysfunction and hypertension: mechanistic links","volume":"15","author":"Hall","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ekir.2026.107038_bib36","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1159\/000500352","article-title":"Prognostic value of microscopic hematuria after induction of remission in antineutrophil cytoplasmic antibodies-associated vasculitis","volume":"49","author":"Vandenbussche","year":"2019","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.ekir.2026.107038_bib37","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.kint.2024.10.018","article-title":"Lupus nephritis: redefining the treatment goals","volume":"107","author":"De Vriese","year":"2025","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2026.107038_bib38","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.amjms.2018.06.005","article-title":"Hematuria and renal outcomes in patients with diabetic chronic kidney disease","volume":"356","author":"Lin","year":"2018","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.ekir.2026.107038_bib39","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00281-021-00882-9","article-title":"Complement activation in IgA nephropathy","volume":"43","author":"Medjeral-Thomas","year":"2021","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.ekir.2026.107038_bib40","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1681\/ASN.2011050464","article-title":"The pathophysiology of IgA nephropathy","volume":"22","author":"Suzuki","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2026.107038_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-65857-w","article-title":"Role of serum complement C3 and C4 on kidney outcomes in IgA nephropathy","volume":"14","author":"Tringali","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.ekir.2026.107038_bib42","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/PAP.0000000000000134","article-title":"Pathophysiology of IgA nephropathy","volume":"24","author":"Al Hussain","year":"2017","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.ekir.2026.107038_bib43","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1046\/j.1523-1755.2000.00101.x","article-title":"Renal response to repetitive exposure to heme proteins: chronic injury induced by an acute insult","volume":"57","author":"Nath","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2026.107038_bib44","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/path.5011","article-title":"Podocytes are new cellular targets of haemoglobin-mediated renal damage","volume":"244","author":"Rubio-Navarro","year":"2018","journal-title":"J Pathol"},{"key":"10.1016\/j.ekir.2026.107038_bib45","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.3390\/ijms20092205","article-title":"Glomerular hematuria: cause or consequence of renal inflammation?","volume":"20","author":"Moreno","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ekir.2026.107038_bib46","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2215\/CJN.02670706","article-title":"Factors that determine an incomplete recovery of renal function in macrohematuria-induced acute renal failure of IgA nephropathy","volume":"2","author":"Guti\u00e9rrez","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2026.107038_bib47","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1007\/s12325-025-03187-7","article-title":"An expert opinion on current and future treatment approaches in IgA nephropathy","volume":"42","author":"Glassock","year":"2025","journal-title":"Adv Ther"},{"key":"10.1016\/j.ekir.2026.107038_bib48","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1093\/ndt\/gfr446","article-title":"Long-term risk of ESRD in IgAN: validation of a Japanese prognostic model in a Norwegian cohort","volume":"27","author":"Bj\u00f8rneklett","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2026.107038_bib49","doi-asserted-by":"crossref","first-page":"72","DOI":"10.15171\/jnp.2016.12","article-title":"Effect of hematuria on the outcome of immunoglobulin A nephropathy with proteinuria","volume":"5","author":"Iwasaki","year":"2016","journal-title":"J Nephropathol"},{"key":"10.1016\/j.ekir.2026.107038_bib50","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1080\/0886022X.2021.1879852","article-title":"Hematuria was a high risk for renal progression and ESRD in immunoglobulin A nephropathy: a systematic review and meta-analysis","volume":"43","author":"He","year":"2021","journal-title":"Ren Fail"},{"key":"10.1016\/j.ekir.2026.107038_bib51","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.kint.2024.03.012","article-title":"A phase 2b, randomized, double-blind, placebo-controlled, clinical trial of atacicept for treatment of IgA nephropathy","volume":"105","author":"Lafayette","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2026.107038_bib52","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1056\/NEJMoa2410316","article-title":"Alternative complement pathway inhibition with iptacopan in IgA nephropathy","volume":"392","author":"Perkovic","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ekir.2026.107038_bib53","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa2305635","article-title":"A phase 2 trial of sibeprenlimab in patients with IgA nephropathy","volume":"390","author":"Mathur","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ekir.2026.107038_bib54","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.urology.2021.04.014","article-title":"Laboratory reporting parameters of microhematuria: implications for interpreting the 2020 AUA guideline","volume":"154","author":"Sternberg","year":"2021","journal-title":"Urology"},{"key":"10.1016\/j.ekir.2026.107038_bib55","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1053\/j.ajkd.2022.02.022","article-title":"Glomerular hematuria and the utility of urine microscopy: a review","volume":"80","author":"Saha","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2026.107038_bib56","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1515\/cclm-2023-0260","article-title":"Pitfalls in the diagnosis of hematuria","volume":"61","author":"Delanghe","year":"2023","journal-title":"Clin Chem Lab Med"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024926032705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024926032705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T20:31:09Z","timestamp":1793737869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024926032705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":56,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S2468024926032705"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2026.107038","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic Review of Persistent Microscopic Hematuria and Kidney Outcomes in IgAN","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2026.107038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2026.106653","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of the International Society of Nephrology.","name":"copyright","label":"Copyright"}],"article-number":"107038"}}